USPTO serial 79433015
CURADERM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 20, 2026
- Examiner
- GANESH, HARINI
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CURADERM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Eberbach, DE
Eberbach, DE
Eberbach, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Douglas M. McAllister
Douglas M. McAllister Lipsitz & McAllister, LLC755 Main Street, Building 8Monroe, CT 06468UNITED STATES OF AMERICAGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical products for industrial and scientific purposes, namely chemical products as active ingredients for use in the manufacture of food products; gelatine glue for industrial purposes; protein in raw material form, in particular for industrial and scientific research purposes and for use in the manufacture of foodstuffs, luxury foodstuffs and beverages, chemical, pharmaceutical, cosmetic and veterinary products and preparations, dietetic products and food supplements; protein in the form of raw material, in particular collagen peptides for scientific purposes; gelatine being raw material, in particular for industrial purposes and for use in the manufacture of foodstuffs and beverages, pharmaceutical, cosmetic and veterinary products, dietetic products and food supplements; gelatine hydrolysate in raw material form, in particular for industrial purposes and for use in the manufacture of foodstuffs and beverages, pharmaceutical, cosmetic and veterinary products, dietetic products and food supplements; collagen in the form of raw material and collagen fibers, in particular for industrial purposes and for use in the manufacture of foodstuffs and beverages, pharmaceutical, cosmetic and veterinary products; collagen hydrolysate being raw material, in particular for industrial purposes and for use in the manufacture of foodstuffs and beverages, pharmaceutical, cosmetic and veterinary products; proteins, in particular collagen peptides, for use in the manufacture of foodstuffs; proteins in raw material form, in particular collagen peptides, for human and animal consumption; proteins, in particular collagen peptides, for human consumption; proteins for human consumption, which form emulsions in the manufacturing process; proteins, in particular collagen peptides, for use in science; protein products in the form of raw material; proteins, in particular collagen peptides, for use in manufacture; proteins for use in the manufacture of beverages; proteins in the form of raw materials, in particular collagen peptides, for use in the manufacture of sports nutrition beverages, athlete nutrition supplements, nutritional supplements for sports and nutritional supplements for athletes in solid, liquid or powder form; proteins, in particular collagen peptides, for use in the manufacture of foods for animals and animal feed; chemical preparations for use as animal feed supplements; proteins, in particular gelatine and gelatine hydrolysate, for use in the manufacture of foods for animals, animal feed supplements and veterinary products and preparations; proteins in the form of raw materials, in particular collagen peptides, for use in the manufacture of food supplements for humans and animals; proteins, in particular collagen peptides, for non-medicinal purposes for use in gene technology; proteins in the form of raw material for use in the manufacture of medicines and pharmaceuticals and preparations for use in the treatment of mental illnesses, for use in wound healing and for use in the treatment of skin diseases; proteins and protein mixtures for industrial and scientific purposes; proteins and protein-containing products in solid, liquid or dissolved form as raw products for use in the preparation of food, for use in the manufacture of pharmaceutical and veterinary products, dietetic products, cosmetic products, for technical purposes and for use in the manufacture of feedstuffs; animal and vegetable proteins in solid or liquid form for industrial or technical purposes; animal and vegetable proteins, fats and oils in solid or liquid form for use in the manufacture of pharmaceuticals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 20, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 20, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 1, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 1, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 26, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 4, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 28, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 28, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 28, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 28, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 26, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 10, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 10, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 15, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 14, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 8, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 22, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 22, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 19, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 19, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 19, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 19, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 18, 2025 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |